Patients With IBS Often Have Negative Health Care Encounters

This article originally appeared here.
Share this content:
Patients With IBS Often Have Negative Health Care Encounters
Patients With IBS Often Have Negative Health Care Encounters

WEDNESDAY, June 1, 2016 (HealthDay News) -- Patients suffering from severe irritable bowel syndrome (IBS) often have negative experiences of health care encounters, and actively negotiate such professional discourse by presenting a counternarrative describing their own suffering and strengths, according to a study published online May 24 in the Journal of Clinical Nursing.

Ida Björkman, R.N., from the University of Gothenburg in Sweden, and colleagues examined patients' experiences of health care encounters in severe IBS. Ten patients were interviewed during 2014 to assess how they actively negotiated professional discourse communicated in the clinical encounter.

The researchers found that patients' experiences of health care encounters were mainly described as negative, with feelings of confusion and self-doubt often induced. Being listened to, believed, and taken seriously were described as positive encounters. Patients found it problematic when IBS was described by health care professionals as a minor disorder with primarily stress or psychological etiology, and holding patients responsible for recovery. By presenting a counternarrative describing their own suffering and strengths, health care shortcomings, and possible organic etiology of IBS, patients actively negotiated such professional discourse.

"Patients suffering from severe IBS described how they often felt a need to protect their positive identities in the face of trivialization and disbelief by health care professionals," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Belimumab Aids Anti-dsDNA, Hypocomplementemic Lupus

Belimumab Aids Anti-dsDNA+, Hypocomplementemic Lupus

More SLE Responder Index responders at week 52 in the belimumab group versus the placebo group

Too Few Adults Taking Epilepsy Meds Have Seizure Control

Too Few Adults Taking Epilepsy Meds Have Seizure ...

Ninety percent of those with active epilepsy take meds; 44 percent of those report seizure control

Pediatric Exposures to Liquid Nicotine Down From 2015 to 2016

Pediatric Exposures to Liquid Nicotine Down From 2015 ...

Still poses serious risk to children; decrease likely in part to law requiring child-resistant packaging

is free, fast, and customized just for you!

Already a member?

Sign In Now »